GLPG3970 oral solution

DRUG2 trials

Sponsors

Galapagos NV

Conditions

HealthyPsoriasis

Phase 1

A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970

CompletedNCT04106297

Galapagos NVHealthy, Psoriasis

Start: 2019-09-10End: 2021-03-05Updated: 2024-09-19

A Study to Assess Relative Bioavailability of and Effect of Food on a New Oral Tablet Formulation of GLPG3970

CompletedNCT04708184

Galapagos NVHealthy

Start: 2021-01-11End: 2021-02-25Updated: 2021-03-25

Related Papers

Effects of GLPG3970 on Sulfasalazine and Methotrexate Pharmacokinetics in Healthy Adults: Two Open‐Label, Phase I, Drug–Drug Interaction Studies

Clinical Pharmacology & Therapeutics2024-11-081 citations